Mphasis Ltd (NSE: MPHASIS)
DII Holding: As of September 2024, DIIs held 36.97% of Mphasis shares, up from 35.94% in the previous quarter.
Promoter Holding: Stood at 40.32%, showing a slight decrease from 40.35% in June 2024.
FII Holding: Foreign Institutional Investors held 18.25%, a marginal decline from 18.32% in the prior quarter.
Public Holding: Decreased to 4.43% from 5.39%.
The rising DII stake suggests growing confidence among domestic institutions in Mphasis’s performance. However, the slight reduction in promoter and public holdings may indicate a shift in investor sentiment.
💊 Gland Pharma Ltd (NSE: GLAND)
DII Holding: Increased to 35.37% in September 2024 from 32.83% in June 2024.
Promoter Holding: Remained stable at 51.83%.
FII Holding: Declined to 4.47% from 6.88%.
Public Holding: Slightly decreased to 8.33% from 8.46%.
The consistent increase in DII holdings over recent quarters indicates sustained domestic institutional interest in Gland Pharma. The stable promoter holding reflects continued commitment from the founding stakeholders.
Both Mphasis and Gland Pharma exhibit strong DII participation, reflecting domestic institutional confidence. Investors may consider monitoring these stocks for potential opportunities, keeping in mind the broader market conditions and company-specific developments.
Always do your own research or consult a financial advisor before investing, especially after such a massive rally